Stereotaxis, Inc. (STXS) intrinsic value & 10-year financials
Stereotaxis, Inc. (STXS) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 0.1% a year to $32.4M, with an average return on invested capital of -620.2%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.01
- Market cap
- $91.9M
- Revenue (FY2025)
- $32.4M
- Revenue growth (10-yr CAGR)
- 0.1%
- ROIC (10-yr avg)
- -620.2%
- Free cash flow (FY2025)
- -$13.8M
STXS 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $32.4M | -$21.6M | -$0.25 | -$13.8M | -68.3% | -1042.3% |
| FY2024 | $26.9M | -$24.0M | -$0.30 | -$8.5M | -91.9% | -5427.8% |
| FY2023 | $26.8M | -$20.7M | -$0.27 | -$9.5M | -81.6% | -166.8% |
| FY2022 | $28.1M | -$18.3M | -$0.26 | -$10.8M | -66.7% | -151.2% |
| FY2021 | $35.0M | -$10.7M | -$0.16 | -$4.3M | -36.8% | 344.9% |
| FY2020 | $26.6M | -$6.6M | -$0.11 | -$3.6M | -25.2% | 106.5% |
| FY2019 | $28.9M | -$4.6M | -$0.10 | -$4.6M | -16.7% | 86.2% |
| FY2018 | $29.3M | $116.8K | -$0.03 | -$2.8M | -8.4% | -0.9% |
| FY2017 | $31.1M | -$5.9M | -$0.32 | -$4.8M | -19.0% | 24.5% |
| FY2016 | $32.2M | -$5.3M | -$0.54 | -$7.0M | -20.0% | 24.6% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Stereotaxis, Inc. has demonstrated mature, steady growth, with revenue compounding at 0.1% annually over the past decade.
Stereotaxis, Inc. has earned high returns on invested capital, averaging 17.6% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Stereotaxis, Inc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Stereotaxis, Inc. is modeled at 0.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1.86 per share.